Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olav Spigset

Showing results (11-20 of 319) with videos related to

Pageof 32
Sort By:
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|September 10, 2004
[Short and good information about drugs]Petter Gjersvik, Olav Spigset
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|April 18, 2009
[Irreversible, non-selective monoamine oxidase inhibitors]Ingrid Castberg, Olav Spigset
Drug Safety|October 30, 2003
Declaration of fructose and fructose-related adverse effects in commercial drug preparations in European countriesArne Reimers, Olav Spigset
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|January 31, 2003
[Interactions with antiepileptics]Eylert Brodtkorb, Olav Spigset
Drug Safety|July 13, 2002
Genotyping of drug targets: a method to predict adverse drug reactions?Cüneyt Güzey, Olav Spigset
Journal of Clinical Psychopharmacology|April 25, 2006
Low serum concentrations of paroxetine in CYP2D6 ultrarapid metabolizersCüneyt Güzey, Olav Spigset
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|June 14, 2006
[Hyponatremia and use of psychopharmaceuticals]Ingrid Castberg, Olav Spigset
Drug Safety|October 11, 2016
Treatment with Selective Serotonin Reuptake Inhibitors in the Third Trimester of Pregnancy : Effects on the InfantHedvig Nordeng, Olav Spigset
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|June 22, 2016
[Serotonergic or serotoninergic syndrome?]Erlend Hem, Olav Spigset
Therapeutic Drug Monitoring|January 25, 2005
Serum concentrations of risperidone and 9-hydroxyrisperidone after administration of the long-acting injectable form of risperidone: evidence from a routine therapeutic drug monitoring serviceIngrid Castberg, Olav Spigset
Pageof 32

Showing results (11-20 of 319) with videos related to

Sort By:
Pageof 32
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|September 10, 2004
[Short and good information about drugs]Petter Gjersvik, Olav Spigset
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|April 18, 2009
[Irreversible, non-selective monoamine oxidase inhibitors]Ingrid Castberg, Olav Spigset
Drug Safety|October 30, 2003
Declaration of fructose and fructose-related adverse effects in commercial drug preparations in European countriesArne Reimers, Olav Spigset
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|January 31, 2003
[Interactions with antiepileptics]Eylert Brodtkorb, Olav Spigset
Drug Safety|July 13, 2002
Genotyping of drug targets: a method to predict adverse drug reactions?Cüneyt Güzey, Olav Spigset
Journal of Clinical Psychopharmacology|April 25, 2006
Low serum concentrations of paroxetine in CYP2D6 ultrarapid metabolizersCüneyt Güzey, Olav Spigset
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|June 14, 2006
[Hyponatremia and use of psychopharmaceuticals]Ingrid Castberg, Olav Spigset
Drug Safety|October 11, 2016
Treatment with Selective Serotonin Reuptake Inhibitors in the Third Trimester of Pregnancy : Effects on the InfantHedvig Nordeng, Olav Spigset
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|June 22, 2016
[Serotonergic or serotoninergic syndrome?]Erlend Hem, Olav Spigset
Therapeutic Drug Monitoring|January 25, 2005
Serum concentrations of risperidone and 9-hydroxyrisperidone after administration of the long-acting injectable form of risperidone: evidence from a routine therapeutic drug monitoring serviceIngrid Castberg, Olav Spigset
Pageof 32